| Source NDC Code |
|
Target HCPCS Code |
49702-0253-15
CABENUVA 400 MG-600 MG ER S
|
⇄
|
C9077
Inj, cabotegravir and rilpivirine, 2mg/3mg
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
09/30/2021 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
49702-0253-15
CABENUVA 400 MG-600 MG ER S
|
⇄
|
J0741
Inj, cabote rilpivir 2mg 3mg
|
| Detail Information |
| Relationship Start Date |
10/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
49702-0253-15
CABENUVA 400 MG-600 MG ER S
|
⇄
|
J3490
Unclassified drugs
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
09/30/2021 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
49702-0253-15
Cabenuva
|
⇄
|
J0741
Inj, cabote rilpivir 2mg 3mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|